We are live on ! Find out more
FRX

FOREST LABORATORIES INC
FRX

Delisted

FRX was delisted on the 30th of June, 2014.

414 hedge funds and large institutions have $19.6B invested in FOREST LABORATORIES INC in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 124 increasing their positions, 198 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more call options, than puts

Call options by funds: $108M | Put options by funds: $81M

6% more funds holding in top 10

Funds holding in top 10: 4750 (+3)

14% less funds holding

Funds holding: 484414 (-70)

17% less capital invested

Capital invested by funds: $23.7B → $19.6B (-$4.02B)

37% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 198

67% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 97

Holders
414
Holders Change
-70
Holders Change %
-14.46%
% of All Funds
11.9%
Holding in Top 10
50
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+6.38%
% of All Funds
1.44%
New
32
Increased
124
Reduced
198
Closed
97
Calls
$108M
Puts
$81M
Net Calls
+$27.3M
Net Calls Change
-$173M
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
276
Sentry Investment Management
Wisconsin
$1.27M -$87.9K -943 -7%
EFSCE
277
Enterprise Financial Services Corp (EFSC)
Missouri
$1.27M -$4.66K -50 -0.4%
Commonwealth Equity Services
278
Commonwealth Equity Services
Massachusetts
$1.2M -$1.01M -10,874 -47%
ACI
279
Alpha Cubed Investments
California
$1.19M +$299K +3,205 +36%
CAIMH
280
Central Asset Investments & Management Holdings
Hong Kong
$1.19M +$1.12M +12,000 New
HPCM
281
High Pointe Capital Management
Illinois
$1.15M -$4.19M -44,900 -79%
SCM
282
Shelton Capital Management
Colorado
$1.14M -$160K -1,720 -13%
DnB Asset Management
283
DnB Asset Management
Norway
$1.14M +$1.07M +11,479 New
SB
284
Suntrust Banks
Georgia
$1.13M -$128K -1,370 -11%
GT
285
Glenmede Trust
Pennsylvania
$1.1M -$124K -1,331 -11%
Federated Hermes
286
Federated Hermes
Pennsylvania
$1.1M +$323K +3,462 +45%
GCP
287
GSA Capital Partners
United Kingdom
$1.1M +$29.9K +321 +3%
CPA
288
Cowen Prime Advisors
New York
$1.01M
OL
289
OTA LLC
New York
$1.01M +$950K +10,183 New
AIM
290
abrdn Investment Management
United Kingdom
$1.01M -$35.6K -382 -4%
STIA
291
Stone Toro Investment Advisers
New Jersey
$990K -$93.3K -1,000 -9%
APFBOT
292
Amica Pension Fund Board of Trustees
Rhode Island
$987K
B
293
Barings
North Carolina
$967K -$110K -1,180 -11%
DL
294
Delta Lloyd
Netherlands
$963K +$161K +1,729 +22%
VRS
295
Virginia Retirement Systems
Virginia
$948K -$7.16M -76,745 -89%
RJT
296
Raymond James Trust
Florida
$942K -$36.3K -389 -4%
BFO
297
Boston Family Office
Massachusetts
$880K
LPL Financial
298
LPL Financial
California
$878K -$1.17M -12,546 -59%
NB
299
Norinchukin Bank
Japan
$873K -$98.2K -1,053 -11%
BNP Paribas Asset Management
300
BNP Paribas Asset Management
France
$846K -$496K -5,319 -38%

FRX Hedge Fund Activity: Q2 2014 in Review

414 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in FOREST LABORATORIES INC (FRX) for Q2 2014, worth a combined $19.6B — down 17% from $23.7B a quarter earlier.

Sellers outnumbered buyers: 97 funds closed out of FRX and 32 opened new positions — a net loss of 65 holders — while 198 trimmed existing stakes and 124 added.

The largest buyer was Farallon Capital Management, adding an estimated $628M. The largest seller was Icahn Carl, exiting entirely with an estimated $2.83B sold.

  • 414 institutional investors held FOREST LABORATORIES INC (FRX) as of Q2 2014, down from 484 in Q1 2014.
  • Funds reported $19.6B of FOREST LABORATORIES INC stock for Q2 2014, down 17% quarter-over-quarter.
  • 32 funds opened new FOREST LABORATORIES INC positions in Q2 2014 and 97 closed out, a net change of -65 holders.
  • The largest FOREST LABORATORIES INC buyer in Q2 2014 was Farallon Capital Management, an estimated $628M added.
  • The largest FOREST LABORATORIES INC seller in Q2 2014 was Icahn Carl, an estimated $2.83B sold.

Based on aggregated 13F filings for Q2 2014.